As of 2026-10-02, the Relative Valuation of Catalyst Pharmaceuticals Inc (CPRX) is 31.26 USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.49 USD, the upside of Catalyst Pharmaceuticals Inc based on Relative Valuation is -0.7%.
The range of the Relative Valuation is 29.41 - 34.82 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.6x - 19.3x | 17.6x |
| Forward P/E multiples | 15.9x - 18.7x | 16.6x |
| Fair Price | 29.41 - 34.82 | 31.26 |
| Upside | -6.6% - 10.6% | -0.7% |
| Date | P/E |
| 2026-07-14 | 17.42 |
| 2026-07-13 | 17.41 |
| 2026-07-10 | 17.41 |
| 2026-07-09 | 17.41 |
| 2026-07-08 | 17.41 |
| 2026-07-07 | 17.42 |
| 2026-07-06 | 17.42 |